The results of hub targets network indicated that 62 hub targets (SRC, MAPK1, MAPK3, STAT3, LCK, PIK3CA, PIK3R1, EGFR, FYN, AKT1, HSP90AA1, RAC1, PTPN11, GRB2, LYN, RELA, MAPK14, IL2, RHOA, HRAS, PTK2, JUN, JAK1, ESR1, STAT5A, TP53, EP300, CTNNB1, STAT1, CREBBP, NRAS, STAT5B, FOS, MYC, MAPK8, VEGFA, PTK2B, SYK, JAK2, NR3C1, NFKBIA, PRKCD, MAP2K1, CDC42, HDAC1, PRKCA, PRKCZ, AR, CCND1, RPS6KB1, HIF1A, RAF1, ITGAV, SFN, ITGB1, ITGB3, ABL1, PPP2CA, IL6, TNF, RXRA, and NCOR2) might be the most important targets of HMMCR for NSCLC. The gene discussed is PTK2; the disease is non-small cell lung carcinoma.